These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29348570)

  • 1. Systematic in vivo evaluation of the time-dependent inflammatory response to steel and Teflon insulin infusion catheters.
    Hauzenberger JR; Münzker J; Kotzbeck P; Asslaber M; Bubalo V; Joseph JI; Pieber TR
    Sci Rep; 2018 Jan; 8(1):1132. PubMed ID: 29348570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detailed Analysis of Insulin Absorption Variability and the Tissue Response to Continuous Subcutaneous Insulin Infusion Catheter Implantation in Swine.
    Hauzenberger JR; Hipszer BR; Loeum C; McCue PA; DeStefano M; Torjman MC; Kaner MT; Dinesen AR; Chervoneva I; Pieber TR; Joseph JI
    Diabetes Technol Ther; 2017 Nov; 19(11):641-650. PubMed ID: 28981324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of steel and teflon infusion catheters on subcutaneous adipose tissue blood flow and infusion counter pressure in humans.
    Højbjerre L; Skov-Jensen C; Kaastrup P; Pedersen PE; Stallknecht B
    Diabetes Technol Ther; 2009 May; 11(5):301-6. PubMed ID: 19425878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study for assessment of optimal frequency for changing catheters in insulin pump therapy-trouble starts on day 3.
    Schmid V; Hohberg C; Borchert M; Forst T; Pfützner A
    J Diabetes Sci Technol; 2010 Jul; 4(4):976-82. PubMed ID: 20663464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Study of the Inflammatory Tissue Response Surrounding a Novel Extended-Wear Kink-Resistant Insulin Infusion Set Prototype Compared With a Commercial Control Over Two Weeks of Wear Time.
    Kastner JR; Eisler G; Torjman MC; Khalf A; Diaz D; Dinesen AR; Loeum C; Strasma PJ; Joseph JI
    J Diabetes Sci Technol; 2023 Nov; 17(6):1563-1572. PubMed ID: 35533132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo investigation of the tissue response to commercial Teflon insulin infusion sets in large swine for 14 days: the effect of angle of insertion on tissue histology and insulin spread within the subcutaneous tissue.
    Eisler G; Kastner JR; Torjman MC; Khalf A; Diaz D; Dinesen AR; Loeum C; Thakur ML; Strasma P; Joseph JI
    BMJ Open Diabetes Res Care; 2019; 7(1):e000881. PubMed ID: 31875136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of infusion set function: steel versus teflon.
    Patel PJ; Benasi K; Ferrari G; Evans MG; Shanmugham S; Wilson DM; Buckingham BA
    Diabetes Technol Ther; 2014 Jan; 16(1):15-9. PubMed ID: 24090124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Infusion Set Materials and Designs on the Subcutaneous Response in People With Diabetes: A Rapid Review of the Literature.
    Hendel K; Stumpe T; Ozer K
    J Diabetes Sci Technol; 2023 Mar; 17(2):314-321. PubMed ID: 36398844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications of intravenous therapy with steel needles and Teflon catheters. A comparative study.
    Tully JL; Friedland GH; Baldini LM; Goldmann DA
    Am J Med; 1981 Mar; 70(3):702-6. PubMed ID: 7211903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Insulin Infusion Sets in CSII for Longer Than the Recommended Usage Time Leads to a High Risk for Adverse Events: Results From a Prospective Randomized Crossover Study.
    Pfützner A; Sachsenheimer D; Grenningloh M; Heschel M; Walther-Johannesen L; Gharabli R; Klonoff D
    J Diabetes Sci Technol; 2015 Sep; 9(6):1292-8. PubMed ID: 26341262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of insulin catheter wear-time on subcutaneous adipose tissue blood flow and insulin absorption in humans.
    Clausen TS; Kaastrup P; Stallknecht B
    Diabetes Technol Ther; 2009 Sep; 11(9):575-80. PubMed ID: 19764836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin Distribution in Human Adipose Tissue via a Novel Insulin Infusion Catheter.
    Altendorfer-Kroath T; Schwingenschuh S; Schøndorff PK; Heschel M; Sinner F; Birngruber T
    Diabetes Technol Ther; 2019 Dec; 21(12):740-744. PubMed ID: 31448965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of peripheral intravenous cannulas in premature infants: a controlled study.
    Batton DG; Maisels MJ; Appelbaum P
    Pediatrics; 1982 Sep; 70(3):487-90. PubMed ID: 7050878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seeking the factors predisposing to local skin inflammatory state development in children with type 1 diabetes (T1DM) treated with continuous subcutaneous insulin infusion (CSII).
    Jarosz-Chobot P; Nowakowska M; Polanska J
    Exp Clin Endocrinol Diabetes; 2007 Mar; 115(3):179-81. PubMed ID: 17427107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue Response to Subcutaneous Infusion Catheter.
    Zhang E; Cao Z
    J Diabetes Sci Technol; 2020 Mar; 14(2):226-232. PubMed ID: 30931603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial.
    Maki DG; Ringer M
    Ann Intern Med; 1991 May; 114(10):845-54. PubMed ID: 2014945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of Catheter Use in Patients with Diabetes Using Continuous Subcutaneous Insulin Infusion: A Review.
    Bonato L; Taleb N; Gingras V; Messier V; Gobeil F; Ménard J; Ardilouze JL; Rabasa-Lhoret R
    Diabetes Technol Ther; 2018 Jul; 20(7):506-515. PubMed ID: 29958025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions and experiences of adult patients with type 1 diabetes using continuous subcutaneous insulin infusion therapy: Results of an online survey.
    Taleb N; Messier V; Ott-Braschi S; Ardilouze JL; Rabasa-Lhoret R
    Diabetes Res Clin Pract; 2018 Oct; 144():42-50. PubMed ID: 30077691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower rate of initial failures and reduced occurrence of adverse events with a new catheter model for continuous subcutaneous insulin infusion: prospective, two-period, observational, multicenter study.
    Renard E; Guerci B; Leguerrier AM; Boizel R;
    Diabetes Technol Ther; 2010 Oct; 12(10):769-73. PubMed ID: 20809682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of infusion rate and indwelling time on tissue resistance pressure in small-volume subcutaneous infusion like in continuous subcutaneous insulin infusion.
    Patte C; Pleus S; Wiegel C; Schiltges G; Jendrike N; Haug C; Freckmann G
    Diabetes Technol Ther; 2013 Apr; 15(4):289-94. PubMed ID: 23427865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.